List of serched triples

A total of 22252 records found

#18272 middle Confidence
Subject: myoepithelial carcinoma (Tumor type)
has
Object: metastasis (Tumor metastasis)
Original: myoepithelial carcinoma#has#increased frequency of local recurrences and metastases compared to its benign counterpart
🏥 Prognosis 📄 PMID: 18306544
#18271 middle Confidence
Subject: myoepithelial carcinoma (Tumor type)
has
Object: local recurrence (Tumor recurrence)
Original: myoepithelial carcinoma#has#increased frequency of local recurrences and metastases compared to its benign counterpart
🏥 Prognosis 📄 PMID: 18306544
#18270 middle Confidence
Subject: Immunohistochemistry (Molecular detection technology)
helps_in_excluding
Object: morphologic_mimics (Morphological artifacts)
Original: Immunohistochemistry#helps in excluding#morphologic mimics
🏥 Diagnostic significance 📄 PMID: 25342157
#18269 middle Confidence
Subject: neoplastic_cells (Tumor cells)
produces
Object: Thyroglobulin (protein)
Original: Immunochemical findings#confirmed#thyroglobulin production by neoplastic cells
🏥 Diagnostic significance 🧬 TG 📄 PMID: 16270269
#18268 middle Confidence
Subject: preoperative_identification_of_poor_prognostic_variant_of_endometrial_carcinoma (Diagnostic Process)
may_influence
Object: choice_of_adjuvant_therapy (Treatment options)
Original: Preoperative identification of poor prognostic variant of endometrial carcinoma#may influence#surgical management and choice of adjuvant therapy
🏥 Treatment guidance 📄 PMID: 15716611
#18267 middle Confidence
Subject: preoperative_identification_of_poor_prognostic_variant_of_endometrial_carcinoma (Diagnostic Process)
may_influence
Object: surgical_management (Treatment options)
Original: Preoperative identification of poor prognostic variant of endometrial carcinoma#may influence#surgical management and choice of adjuvant therapy
🏥 Treatment guidance 📄 PMID: 15716611
#18266 middle Confidence
Subject: Anaplastic_cells (Tumor cells)
have
Object: abundant_cytoplasm (Cytoplasmic morphology)
Original: Anaplastic cells#have#prominent nucleoli and abundant cytoplasm
🏥 not_specified 📄 PMID: 33825717
#18265 middle Confidence
Subject: Anaplastic_cells (Tumor cells)
have
Object: prominent_nucleoli (Nuclear morphology)
Original: Anaplastic cells#have#prominent nucleoli and abundant cytoplasm
🏥 not_specified 📄 PMID: 33825717
#18264 middle Confidence
Subject: Anaplastic_cells (Tumor cells)
have
Object: large_vesicular_pleomorphic_nuclei (Nuclear morphology)
Original: Anaplastic cells#have#large vesicular pleomorphic nuclei
🏥 not_specified 📄 PMID: 33825717
#18263 middle Confidence
Subject: HG_component (Organizational Structure)
is_composed_of
Object: solid_nests_of_anaplastic_cells (Cell structure)
Original: HG component#is composed of#solid nests of anaplastic cells
🏥 not_specified 📄 PMID: 33825717
#18262 middle Confidence
Subject: Tumor_cells (cancer cell)
weakly_expresses
Object: CD56 (Cell adhesion molecules)
Original: Tumor cells#weakly expressed#synaptophysin and CD56
🏥 Diagnostic significance 🧬 SYP/CD56 📄 PMID: 27006299
#18261 middle Confidence
Subject: Tumor_cells (cancer cell)
weakly_expresses
Object: synaptophysin (Neuroendocrine markers)
Original: Tumor cells#weakly expressed#synaptophysin and CD56
🏥 Diagnostic significance 🧬 SYP/CD56 📄 PMID: 27006299
#18260 middle Confidence
Subject: Ewing_sarcoma/primitive_neuroectodermal_tumor (Tumor)
mainly_occurs_in
Object: bone (organ)
Original: Ewing sarcoma/primitive neuroectodermal tumor (ES/PNET)#mainly occurs in#bone or soft tissue of children or young adults
🏥 Epidemiology 📄 PMID: 27006299
#18259 middle Confidence
Subject: cytologic_studies (Cytology)
are_evaluated_for
Object: diagnostic_significance_in_pancreatic_tumors (Diagnostic significance)
Original: Cytologic studies#are evaluated for#diagnostic significance in pancreatic tumors
🏥 Diagnostic significance 📄 PMID: 16756163
#18258 middle Confidence
Subject: metastasis_from_malignant_ameloblastoma (Disease process)
is_described_with
Object: histological_confirmation (Diagnostic techniques)
Original: metastasis from malignant ameloblastoma#is described with#histological confirmation
🏥 Diagnostic significance 📄 PMID: 9484641
#18257 middle Confidence
Subject: IDH2_mutated_sinonasal_tumor_cohort (Tumor Cohort)
has
Object: distinct_features (Disease phenotype)
Original: IDH2-mutated sinonasal tumor cohort#has#distinct features
🏥 Molecular typing 🧬 IDH2 📄 PMID: 34265800
#18256 middle Confidence
Subject: SCCs (Tumor type)
are_characterized_by
Object: small_to_medium_sized_round_to_spindle_shaped_cells_with_scanty_cytoplasm_hyperchromatic_nuclei_and_inconspicuous_nucleoli (Cell morphology)
Original: SCCs#are characterized by#small to medium-sized round to spindle-shaped cells with scanty cytoplasm/ hyperchromatic nuclei/ and inconspicuous nucleoli
🏥 not_specified 📄 PMID: 12656306
#18255 middle Confidence
Subject: Highly differentiated tumors (Tumor differentiation phenotype)
are_associated_with
Object: P+ receptor status (Progesterone receptor positive)
Original: Highly differentiated tumors#are associated with#E+P+ receptor status
🏥 Diagnostic markers 📄 PMID: 3763476
#18254 middle Confidence
Subject: Highly differentiated tumors (Tumor differentiation phenotype)
are_associated_with
Object: E+ receptor status (Estrogen receptor positive)
Original: Highly differentiated tumors#are associated with#E+P+ receptor status
🏥 Diagnostic markers 📄 PMID: 3763476
#18253 middle Confidence
Subject: Cellular type of melanoma (Tumor cell type)
must_be_defined_to
Object: proper method of treatment (Treatment)
Original: Cellular type of melanoma#must be defined#to choose the proper method of treatment
🏥 Treatment guidance 📄 PMID: 6573087